Dashboard
Manage Tickers

ALBOALBIREO PHARMA, INC.

Nasdaq albireopharma.com


$ 44.29 $ -0.10 (-0.23 %)    

Thursday, 02-Mar-2023 15:59:58 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 44.15
$ 43.90 x 500
$ 53.41 x 100
-- - --
$ 16.02 - $ 45.23
1,241,282
na
867.78M
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-08-2022 09-30-2022 10-Q
2 08-15-2022 06-30-2022 10-Q
3 05-16-2022 03-31-2022 10-Q
4 03-01-2022 12-31-2021 10-K
5 11-04-2021 09-30-2021 10-Q
6 08-05-2021 06-30-2021 10-Q
7 05-06-2021 03-31-2021 10-Q
8 02-25-2021 12-31-2020 10-K
9 11-05-2020 09-30-2020 10-Q
10 08-06-2020 06-30-2020 10-Q
11 05-07-2020 03-31-2020 10-Q
12 03-02-2020 12-31-2019 10-K
13 11-06-2019 09-30-2019 10-Q
14 08-08-2019 06-30-2019 10-Q
15 05-09-2019 03-31-2019 10-Q
16 03-06-2019 12-31-2018 10-K
17 11-08-2018 09-30-2018 10-Q
18 08-09-2018 06-30-2018 10-Q
19 05-10-2018 03-31-2018 10-Q
20 03-27-2018 12-31-2017 10-K
21 11-14-2017 09-30-2017 10-Q
22 08-21-2017 06-30-2017 10-Q
23 05-11-2017 03-31-2017 10-Q
24 03-27-2017 12-31-2016 10-K
25 12-22-2016 09-30-2016 10-K
26 08-11-2016 06-30-2016 10-Q
27 05-10-2016 03-31-2016 10-Q
28 02-16-2016 12-31-2015 10-Q
29 12-22-2015 09-30-2015 10-K
30 08-14-2015 06-30-2015 10-Q
31 05-07-2015 03-31-2015 10-Q
32 02-12-2015 12-31-2014 10-Q
33 12-19-2014 09-30-2014 10-K
34 08-13-2014 06-30-2014 10-Q
35 05-14-2014 03-31-2014 10-Q
36 02-10-2014 12-31-2013 10-Q
37 12-20-2013 09-30-2013 10-K
38 08-14-2013 06-30-2013 10-Q
39 05-13-2013 03-31-2013 10-Q
40 02-14-2013 12-31-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

analyst-ratings-for-albireo-pharma
Analyst Ratings for Albireo Pharma
02/15/2023 13:01:22

hc-wainwright--co-reiterates-neutral-on-albireo-pharma-maintains-42-price-target
HC Wainwright & Co. Reiterates Neutral on ...
02/15/2023 09:55:37

HC Wainwright & Co. analyst Ed Arce reiterates Albireo Pharma (NASDAQ:ALBO) with a Neutral and maintains $42 price target.

fda-grants-june-15-2023-pdufa-date-to-albireo-for-bylvay-in-alagille-syndrome
FDA Grants June 15, 2023 PDUFA Date To Alb...
02/14/2023 13:32:31

cowen--co-downgrades-albireo-pharma-heres-what-you-need-to-know
Cowen & Co. Downgrades Albireo Pharma: Her...
01/11/2023 17:00:17

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
01/11/2023 15:01:02

guggenheim-downgrades-albireo-pharma-to-neutral
Guggenheim Downgrades Albireo Pharma to Ne...
01/11/2023 14:22:45

Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.

expert-ratings-for-albireo-pharma
Expert Ratings for Albireo Pharma
01/11/2023 12:00:20

cowen--co-downgrades-albireo-pharma-to-market-perform-lowers-price-target-to-48
Cowen & Co. Downgrades Albireo Pharma to M...
01/11/2023 09:54:29

Cowen & Co. analyst Ritu Baral downgrades Albireo Pharma (NASDAQ:ALBO) from Outperform to Market Perform and lowers the ...

jefferies-downgrades-albireo-pharma-to-hold-lowers-price-target-to-42
Jefferies Downgrades Albireo Pharma to Hol...
01/11/2023 09:52:09

Jefferies analyst Eun Yang downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Hold and lowers the price target from $49 to ...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
01/10/2023 15:01:12

hc-wainwright--co-downgrades-albireo-pharma-to-neutral-announces-42-price-target
HC Wainwright & Co. Downgrades Albireo Pha...
01/10/2023 14:53:41

HC Wainwright & Co. analyst Ed Arce downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral and announces $42 price ...

sp-500-gains-06-albireo-pharma-shares-spike-higher
S&P 500 Gains 0.6%; Albireo Pharma Shares ...
01/09/2023 19:27:02

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday.

why-cutera-shares-are-trading-lower-by-23-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Cutera Shares Are Trading Lower By 23%...
01/09/2023 18:42:49

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the comp...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
01/09/2023 17:30:53

nasdaq-surges-over-200-points-crude-oil-rises-2
Nasdaq Surges Over 200 Points; Crude Oil R...
01/09/2023 17:07:11

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.

tesla-zillow-albireo-pharma-and-some-other-big-stocks-moving-higher-on-monday
Tesla, Zillow, Albireo Pharma And Some Oth...
01/09/2023 15:36:38

U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
01/09/2023 15:01:04

us-stocks-open-higher-dow-rises-150-points
US Stocks Open Higher; Dow Rises 150 Points
01/09/2023 14:59:52

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.

wedbush-downgrades-albireo-pharma-to-neutral-lowers-price-target-to-42
Wedbush Downgrades Albireo Pharma to Neutr...
01/09/2023 13:47:23

Wedbush analyst Andreas Argyrides downgrades Albireo Pharma (NASDAQ:ALBO) from Outperform to Neutral and lowers the price ta...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
01/09/2023 13:05:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION